human | Q5 |
P496 | ORCID iD | 0000-0002-8090-1073 |
P1053 | ResearcherID | C-7043-2008 |
P1153 | Scopus author ID | 57191166856 |
P734 | family name | Díaz | Q5255562 |
Díaz | Q5255562 | ||
Díaz | Q5255562 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q37775727 | Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology. |
Q44808944 | Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus. |
Q34569610 | Cytokine profiles and phenotype regulation of antigen presenting cells by genotype-I porcine reproductive and respiratory syndrome virus isolates |
Q57207428 | Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets |
Q45416506 | Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. |
Q38441596 | Distinct functional enrichment of transcriptional signatures in pigs with high and low IFN-gamma responses after vaccination with a porcine reproductive and respiratory syndrome virus (PRRSV). |
Q40298624 | Effects of challenge with a virulent genotype II strain of porcine reproductive and respiratory syndrome virus on piglets vaccinated with an attenuated genotype I strain vaccine. |
Q40317891 | Estimation of the transmission parameters for swine influenza and porcine reproductive and respiratory syndrome viruses in pigs from weaning to slaughter under natural conditions. |
Q28748169 | Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs |
Q40257435 | Immunization with DNA vaccines containing porcine reproductive and respiratory syndrome virus open reading frames 5, 6, and 7 may be related to the exacerbation of clinical disease after an experimental challenge. |
Q39777872 | Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs. |
Q30235375 | Next-generation sequencing as a tool for the study of Porcine reproductive and respiratory syndrome virus (PRRSV) macro- and micro- molecular epidemiology. |
Q112705478 | Porcine reproductive and respiratory syndrome virus impacts on gut microbiome in a strain virulence-dependent fashion |
Q40259551 | Predicted peptides from non-structural proteins of porcine reproductive and respiratory syndrome virus are able to induce IFN-γ and IL-10. |
Q45358655 | Subclinical porcine circovirus type 2 infection does not modulate the immune response to an Aujeszky's disease virus vaccine. |
Q36888431 | The challenge of PRRS immunology. |
Q40296647 | Transmission of Porcine reproductive and respiratory syndrome virus 1 to and from vaccinated pigs in a one-to-one model. |
Q35940931 | Use of H-Index and Other Bibliometric Indicators to Evaluate Research Productivity Outcome on Swine Diseases |
Q90424809 | Using commercial ELISAs to assess humoral response in sows repeatedly vaccinated with modified live porcine reproductive and respiratory syndrome virus |
Q41640514 | Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental model |